They showed that the diagnostic sensitivity and specificity for osteopontin in ovarian cancer were 0.766 (95% CI 0.685–0.831) and 0.897 (95% CI 0.849–0.931), respectively. This evidence concerns the gene SPP1 and ovarian carcinoma.